United States · FDA National Drug Code directory
URIBEL TABS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0178-0745_47e8083a-60e6-b517-e063-6294a90ac104
- Product NDC
- 0178-0745
- Form
- TABLET, COATED
- Composition / generic term
- Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
- Labeler
- Mission Pharmacal Company
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20231107
- Source listing expiry
- 20271231
Source-listed ingredients
- HYOSCYAMINE SULFATE — .12 mg/1
- PHENYL SALICYLATE — 36.2 mg/1
- METHENAMINE — 81.6 mg/1
- METHYLENE BLUE — 10.8 mg/1
- BENZOIC ACID — 9 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOTTLE (0178-0745-01) · 0178-0745-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →